|Bid||25.40 x 800|
|Ask||25.44 x 1800|
|Day's range||25.00 - 26.00|
|52-week range||15.58 - 68.65|
|Beta (5Y monthly)||1.14|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Castle Biosciences, Inc. ( NASDAQ:CSTL ) shareholders will have a reason to smile today, with the analysts making...
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 89.66% and 22.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lumos (LUMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.